 Myocardial Infarction
"Myocardial Infarction" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
NECROSIS of the MYOCARDIUM caused by an obstruction of the blood supply to the heart (CORONARY CIRCULATION).
| Descriptor ID |
D009203
|
| MeSH Number(s) |
C14.280.647.500 C14.907.585.500
|
| Concept/Terms |
Myocardial Infarction- Myocardial Infarction
- Infarction, Myocardial
- Infarctions, Myocardial
- Myocardial Infarctions
- Cardiovascular Stroke
- Cardiovascular Strokes
- Stroke, Cardiovascular
- Strokes, Cardiovascular
- Heart Attack
- Heart Attacks
- Myocardial Infarct
- Infarct, Myocardial
- Infarcts, Myocardial
- Myocardial Infarcts
|
Below are MeSH descriptors whose meaning is more general than "Myocardial Infarction".
Below are MeSH descriptors whose meaning is more specific than "Myocardial Infarction".
This graph shows the total number of publications written about "Myocardial Infarction" by people in this website by year, and whether "Myocardial Infarction" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1992 | 3 | 0 | 3 | | 1993 | 3 | 3 | 6 | | 1994 | 5 | 0 | 5 | | 1995 | 2 | 2 | 4 | | 1996 | 5 | 1 | 6 | | 1997 | 5 | 0 | 5 | | 1998 | 5 | 1 | 6 | | 1999 | 2 | 0 | 2 | | 2000 | 4 | 4 | 8 | | 2001 | 17 | 2 | 19 | | 2002 | 13 | 3 | 16 | | 2003 | 16 | 8 | 24 | | 2004 | 10 | 7 | 17 | | 2005 | 19 | 6 | 25 | | 2006 | 32 | 6 | 38 | | 2007 | 35 | 8 | 43 | | 2008 | 26 | 11 | 37 | | 2009 | 30 | 10 | 40 | | 2010 | 32 | 7 | 39 | | 2011 | 29 | 12 | 41 | | 2012 | 22 | 10 | 32 | | 2013 | 43 | 14 | 57 | | 2014 | 52 | 17 | 69 | | 2015 | 46 | 5 | 51 | | 2016 | 47 | 9 | 56 | | 2017 | 24 | 12 | 36 | | 2018 | 29 | 11 | 40 | | 2019 | 20 | 17 | 37 | | 2020 | 30 | 6 | 36 | | 2021 | 17 | 3 | 20 |
To return to the timeline, click here.
Below are the most recent publications written about "Myocardial Infarction" by people in Profiles.
-
Navarese EP, Lansky AJ, Kereiakes DJ, Kubica J, Gurbel PA, Gorog DA, Valgimigli M, Curzen N, Kandzari DE, Bonaca MP, Brouwer M, Uminska J, Jaguszewski MJ, Raggi P, Waksman R, Leon MB, Wijns W, Andreotti F. Cardiac mortality in patients randomised to elective coronary revascularisation plus medical therapy or medical therapy alone: a systematic review and meta-analysis. Eur Heart J. 2021 12 01; 42(45):4638-4651.
-
Schena GJ, Murray EK, Hildebrand AN, Headrick AL, Yang Y, Koch KA, Kubo H, Eaton D, Johnson J, Berretta R, Mohsin S, Kishore R, McKinsey TA, Elrod JW, Houser SR. Cortical bone stem cell-derived exosomes' therapeutic effect on myocardial ischemia-reperfusion and cardiac remodeling. Am J Physiol Heart Circ Physiol. 2021 12 01; 321(6):H1014-H1029.
-
Hobby ARH, Berretta RM, Eaton DM, Kubo H, Feldsott E, Yang Y, Headrick AL, Koch KA, Rubino M, Kurian J, Khan M, Tan Y, Mohsin S, Gallucci S, McKinsey TA, Houser SR. Cortical bone stem cells modify cardiac inflammation after myocardial infarction by inducing a novel macrophage phenotype. Am J Physiol Heart Circ Physiol. 2021 10 01; 321(4):H684-H701.
-
Lesén E, Hewitt C, Giannitsis E, Hedberg J, Jernberg T, Lambrelli D, Maggioni AP, Simeone JC, Ariza-Solé A, Storey RF, Ten Berg J, Bonaca M. Extended dual antiplatelet therapy with ticagrelor 60?mg in patients with prior myocardial infarction: The design of ALETHEIA, a multi-country observational study. Clin Cardiol. 2021 Oct; 44(10):1333-1343.
-
Oyama Y, Walker LA, Eckle T. Targeting circadian PER2 as therapy in myocardial ischemia and reperfusion injury. Chronobiol Int. 2021 09; 38(9):1262-1273.
-
Dagenais GR, Dyal L, Bosch JJ, Leong DP, Aboyans V, Berkowitz SD, Bhatt DL, Connolly SJ, Fox KAA, Muehlhofer E, Probstfield JL, Widimsky P, Winkelmann BR, Yusuf S, Eikelboom JW. Cardiovascular consequences of discontinuing low-dose rivaroxaban in people with chronic coronary or peripheral artery disease. Heart. 2021 07; 107(14):1130-1137.
-
Jones WS, Mulder H, Wruck LM, Pencina MJ, Kripalani S, Muñoz D, Crenshaw DL, Effron MB, Re RN, Gupta K, Anderson RD, Pepine CJ, Handberg EM, Manning BR, Jain SK, Girotra S, Riley D, DeWalt DA, Whittle J, Goldberg YH, Roger VL, Hess R, Benziger CP, Farrehi P, Zhou L, Ford DE, Haynes K, VanWormer JJ, Knowlton KU, Kraschnewski JL, Polonsky TS, Fintel DJ, Ahmad FS, McClay JC, Campbell JR, Bell DS, Fonarow GC, Bradley SM, Paranjape A, Roe MT, Robertson HR, Curtis LH, Sharlow AG, Berdan LG, Hammill BG, Harris DF, Qualls LG, Marquis-Gravel G, Modrow MF, Marcus GM, Carton TW, Nauman E, Waitman LR, Kho AN, Shenkman EA, McTigue KM, Kaushal R, Masoudi FA, Antman EM, Davidson DR, Edgley K, Merritt JG, Brown LS, Zemon DN, McCormick TE, Alikhaani JD, Gregoire KC, Rothman RL, Harrington RA, Hernandez AF. Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease. N Engl J Med. 2021 05 27; 384(21):1981-1990.
-
Goyal N, Herrick JS, Son S, Metz TD, Shah RU. Maternal cardiovascular complications at the time of delivery and subsequent re-hospitalization in the USA, 2010-16. Eur Heart J Qual Care Clin Outcomes. 2021 05 03; 7(3):304-311.
-
Sidebottom AC, Miedema MD, Benson G, Vacquier M, VanWormer JJ, Sillah A, Lindberg R, Boucher JL, Bradley SM. The impact of a population-based prevention program on cardiovascular events: Findings from the heart of new Ulm project. Am Heart J. 2021 09; 239:38-51.
-
Berg DD, Freedman BL, Bonaca MP, Jarolim P, Scirica BM, Goodrich EL, Sabatine MS, Morrow DA. Cardiovascular Biomarkers and Heart Failure Risk in Stable Patients With Atherothrombotic Disease: A Nested Biomarker Study From TRA 2°P-TIMI 50. J Am Heart Assoc. 2021 05 04; 10(9):e018673.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|